Skip to main content

FDA to meet over Moderna, Johnson & Johnson vaccine booster shots

The U.S. Food and Drug Administration (FDA) will meet this week to debate whether or not extra doses of the Moderna, Inc. and Johnson & Johnson Janssen vaccines should be distributed, to whom and when.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.